These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19098912)

  • 21. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin.
    Borelli I; Barberis MA; Spina F; Casalis Cavalchini GC; Vivanet C; Balestrino L; Micheletti M; Allavena A; Sala P; Carcassi C; Pasini B
    Eur J Hum Genet; 2013 Feb; 21(2):154-61. PubMed ID: 22781090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome.
    Liu Q; Hesson LB; Nunez AC; Packham D; Williams R; Ward RL; Sloane MA
    Carcinogenesis; 2016 Jan; 37(1):10-17. PubMed ID: 26498247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel MLH1 duplication identified in Colombian families with Lynch syndrome.
    Alonso-Espinaco V; Giráldez MD; Trujillo C; van der Klift H; Muñoz J; Balaguer F; Ocaña T; Madrigal I; Jones AM; Echeverry MM; Velez A; Tomlinson I; Milà M; Wijnen J; Carvajal-Carmona L; Castells A; Castellví-Bel S
    Genet Med; 2011 Feb; 13(2):155-60. PubMed ID: 21233718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
    Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
    World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.
    Chan TL; Yuen ST; Kong CK; Chan YW; Chan AS; Ng WF; Tsui WY; Lo MW; Tam WY; Li VS; Leung SY
    Nat Genet; 2006 Oct; 38(10):1178-83. PubMed ID: 16951683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alu in Lynch syndrome: a danger SINE?
    Hitchins MP; Burn J
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1527-30. PubMed ID: 21972078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
    Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
    Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
    Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
    Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
    Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
    Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer.
    Zheng D; Li T; Liu X; Hu W; Chen H; Yang Y
    Int J Colorectal Dis; 2007 Aug; 22(8):875-9. PubMed ID: 17333219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.
    Bianchi F; Maccaroni E; Belvederesi L; Brugiati C; Giampieri R; Bini F; Bracci R; Pagliaretta S; Del Prete M; Piva F; Mandolesi A; Scarpelli M; Berardi R
    Fam Cancer; 2018 Apr; 17(2):215-224. PubMed ID: 28785832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
    Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
    Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.